Results 61 to 70 of about 786,314 (373)

Impulse Control Disorders by Dopamine Partial Agonists: A Pharmacovigilance-Pharmacodynamic Assessment Through the FDA Adverse Event Reporting System

International Journal of Neuropsychopharmacology, 2022
Background The dopaminergic partial agonism of the so-called third-generation antipsychotics (TGAs; aripiprazole, brexpiprazole, cariprazine) is hypothesized to cause impulse control disorders (ICDs). Relevant warnings by the Food and Drug Administration
M. Fusaroli, E. Raschi, V. Giunchi, M. Menchetti, Roberto Rimondini Giorgini, F. De Ponti, E. Poluzzi   +6 more
semanticscholar   +1 more source

Adverse Events Related to Off-Label Drugs Using Spontaneous Adverse Event Reporting Systems

Therapeutics and Clinical Risk Management, 2021
The purpose of this study was to investigate the adverse events (AEs) related to the use of off-label drugs.A cross-sectional study was carried out using available data pertaining to off-label drug were sourced from U.S. FDA spontaneous adverse drug reaction reporting database (FAERS) and Korea Adverse Event Reporting System database (KIDS-KD) for the ...
In-Wha Kim, Nayoung Han, Nayoung Han, Jung Mi Oh   +3 more
openaire   +5 more sources

Indication and adverse event profiles of denosumab and zoledronic acid: based on U.S. FDA adverse event reporting system (FAERS)

Frontiers in Pharmacology, 2023
Objective: To investigate adverse events (AEs) associated with denosumab (Dmab) and zoledronic acid (ZA), compare their association strengths, and explore potential applications to provide clinical reference.Methods: We collected data from FAERS from ...
Si Su, Si Su, Liuqing Wu, Guibao Zhou, Lingling Peng, Huanzhe Zhao, Xiao Wang, Xiao Wang, Kuan Li   +8 more
doaj   +1 more source

Psychiatric adverse events associated with GLP-1 receptor agonists: a real-world pharmacovigilance study based on the FDA Adverse Event Reporting System database

Frontiers in Endocrinology
Background Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are widely used due to their profound efficacy in glycemic control and weight management.
Wei Chen, Peishan Cai, Wenbin Zou, Zhiwen Fu   +3 more
semanticscholar   +1 more source

Adverse event reporting and patient safety at a University Hospital: Mapping, correlating and associating events for a data-based patient risk management [PDF]

, 2016
BACKGROUND: Reporting adverse events (AE) with a bearing on patient safety is fundamentally important to the identification and mitigation of potential clinical risks.
Baldo, Vincenzo, Buja, Alessandra, Cacco, Rosaria Manola, Dario, Claudio, DE BATTISTI, Elisa, Ottolitri, Ketty, Saieva, ANNA MARIA, Vinelli, Angela   +7 more
core   +1 more source

A real-world disproportionality analysis of Everolimus: data mining of the public version of FDA adverse event reporting system

Frontiers in Pharmacology
Background: Everolimus is an inhibitor of the mammalian target of rapamycin and is used to treat various tumors. The presented study aimed to evaluate the Everolimus-associated adverse events (AEs) through data mining of the US Food and Drug ...
Bin Zhao, Yumei Fu, Shichao Cui, Xiangning Chen, Shu Liu, Lan Luo   +5 more
semanticscholar   +1 more source

Analysis of Adverse Drug Reactions to First-Line Anti-Tuberculosis Drugs Using the Korea Adverse Event Reporting System

Journal of Korean medical science, 2022
Background Adverse drug reactions (ADRs) to first-line anti-tuberculosis (TB) drugs are common; however, there have been few reports of nationwide epidemiologic studies on ADRs to anti-TB drugs in Korea.
S. Chung, Sun-ju Byeon, Jeong-Hee Choi
semanticscholar   +1 more source

Adverse Events During Pregnancy Associated With Entecavir and Adefovir: New Insights From a Real-World Analysis of Cases Reported to FDA Adverse Event Reporting System

Frontiers in Pharmacology, 2022
Background: Due to the embryotoxicity found in animal studies and scarce clinical data in pregnant women, it is still controversial whether entecavir (ETV) and adefovir dipivoxil (ADV) are safe during human pregnancy. This is of paramount importance when
Renjun Yang, Nuoya Yin, Ying Zhao, Dandan Li, Xuanling Zhang, Xingang Li, Yang-Yang Zhang, F. Faiola   +7 more
semanticscholar   +1 more source

Ontology Modelling for FDA Adverse Event Reporting System [PDF]

, 2016
Ontologies are relevant to a specific knowledge or application domain and it represents a set of concepts and their inter-relationships. Ontological design comprises of ontology development process, the ontology life cycle, the techniques and ...
, Rima Borah, Rajarajeswari S.
core   +2 more sources

Cardiovascular Toxicity of Tyrosine Kinase Inhibitors Used in Chronic Myeloid Leukemia: An Analysis of the FDA Adverse Event Reporting System Database (FAERS)

Cancers, 2020
Tyrosine kinase inhibitors (TKIs), the treatment of choice for chronic myeloid leukemia (CML), can be associated to cardiovascular (CV) adverse events (AEs).
S. Cirmi, Asmae El Abd, L. Létinier, M. Navarra, F. Salvo   +4 more
semanticscholar   +1 more source